PIVEZLA
Live / Registered — Registered (as of 24 Aug 2021)
What this means for you
Registered since 24 Aug 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 affidavit of use is due by 24 Aug 2027, and its filing window is open now).
Record
- Serial number
- 79302151
- Registration number
- 6458410
- Mark type
- Word mark
- Filed
- 18 Nov 2020
- Published for opposition
- 08 Jun 2021
- Registered
- 24 Aug 2021
- Next maintenance filing
- §71 affidavit of use, due by 24 Aug 2027 (grace period to 24 Feb 2028)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
Owner
Prosecution history
- 30 May 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Aug 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 08 Nov 2021 — NOTIFICATION PROCESSED BY IB
- 20 Oct 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 15 Oct 2021 — FINAL DISPOSITION PROCESSED
- 23 Sept 2021 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 24 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2021 — PUBLISHED FOR OPPOSITION
- 19 May 2021 — NOTICE OF PUBLICATION
- 04 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Apr 2021 — ASSIGNED TO EXAMINER
- 23 Jan 2021 — APPLICATION FILING RECEIPT MAILED
- 19 Jan 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Jan 2021 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 14 Jan 2021 — SN ASSIGNED FOR SECT 66A APPL FROM IB